Condensed Consolidated Statements Of Comprehensive Income/(Loss) (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|||
| Revenue: | ||||||
| Total revenues | $ 0 | $ 0 | $ 0 | $ 0 | ||
| Operating expenses | ||||||
| Research and development | 209,087 | 220,714 | 358,285 | 526,795 | ||
| General and administrative | 238,429 | 101,768 | 506,551 | 289,870 | ||
| Total operating expenses | 447,516 | 322,482 | 864,836 | 816,665 | ||
| Loss from operations | (447,516) | (322,482) | (864,836) | (816,665) | ||
| Interest income | 54,485 | 0 | 64,018 | 0 | ||
| Net loss | (393,031) | (322,482) | (800,818) | (816,665) | ||
| Other comprehensive income (loss): | ||||||
| Foreign Currency Transaction Adjustment | 159,309 | 140,312 | 362,064 | (389,703) | ||
| Comprehensive loss | $ (233,722) | $ (182,170) | $ (438,754) | $ (1,206,368) | ||
| Loss per share | ||||||
| Basic and diluted | [1] | |||||
| Weighted Average Number of Shares Outstanding | 205,000,000 | 205,000,000 | 205,000,000 | 205,000,000 | ||
| ||||||